治療用RNAiのインド市場(現状と見通し)

【英語タイトル】2017-2022 India RNAi for Therapeutic Market Report (Status and Outlook)

LP Informationが出版した調査資料(LPI705538)・商品コード:LPI705538
・発行会社(調査会社):LP Information
・発行日:2017年5月2日
・ページ数:115
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:インド
・産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD3,360 ⇒換算¥362,880見積依頼/購入/質問フォーム
Corporate UserUSD6,720 ⇒換算¥725,760見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

The RNAi for Therapeutic market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.
In India market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as
Alnylam Pharmaceuticals
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
miRagen Therapeutics
Gradalis
Sirnaomics

Split by product types/category, covering many types. with sales, revenue and market share for each type, such as
siRNA
miRNA
shRNA

Split by applications/end use industries, covers many application. This report focuses on sales, market share and growth rate of RNAi for Therapeutic in each application.suach as
Cancer
Cardiovascular
HBV
Other

【レポートの目次】

Table of Contents

2017-2022 India RNAi for Therapeutic Market Report (Status and Outlook)
1 RNAi for Therapeutic Market Overview
1.1 Product Overview and Scope of RNAi for Therapeutic
1.2 RNAi for Therapeutic Market Segment by Types
1.2.1 India RNAi for Therapeutic Sales Present Situation and Outlook by Types (2012-2022)
1.2.2 India RNAi for Therapeutic Sales Market Share by Types in 2016
1.2.3 siRNA
1.2.4 miRNA
shRNA
1.3 India RNAi for Therapeutic Market Segment by Applications/End Use Industries
1.3.1 India RNAi for Therapeutic Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
1.3.2 India RNAi for Therapeutic Sales Market Share by Types in 2016
1.3.3 Cancer
1.3.4 Cardiovascular
1.3.5 HBV
Other
1.4 India RNAi for Therapeutic Overview and Market Size (Value) (2012-2022)
1.4.1 India Market RNAi for Therapeutic Overview
1.4.2 India RNAi for Therapeutic Market Size (Value and Volume) Status and Forecast (2012-2022)
2 India RNAi for Therapeutic Sales, Revenue (Value) and Market Share by Vendors/Manufacturers
2.1 India RNAi for Therapeutic Sales and Market Share (2012-2017) by Vendors/Manufacturers
2.2 India RNAi for Therapeutic Revenue and Market Share by Vendors (2012-2017)
2.3 India RNAi for Therapeutic Average Price by Vendors in 2016
2.4 India RNAi for Therapeutic Manufacturing Base Distribution, Sales Area, Product Types by Vendors
2.5 RNAi for Therapeutic Market Competitive Situation and Trends
2.5.1 RNAi for Therapeutic Market Concentration Rate
2.5.2 RNAi for Therapeutic Market Share of Top 3 and Top 5 Vendors
2.5.3 Mergers & Acquisitions, Expansion
3 India RNAi for Therapeutic Sales, Revenue (Value) by Type and Application (2012-2017)
3.1 India RNAi for Therapeutic Sales, Revenue, Market Share and Price by Type (2012-2017)
3.1.1 India RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
3.1.2 India RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
3.1.3 India RNAi for Therapeutic Price by Type (2012-2017)
3.2 India RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
3.3 India Market RNAi for Therapeutic Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
4 India RNAi for Therapeutic Vendors/Manufacturers Profiles and Sales Data
4.1 Alnylam Pharmaceuticals
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 RNAi for Therapeutic Product Types, Application and Specification
4.1.2.1 Category One
4.1.2.2 Category Two
4.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.1.4 Main Business/Business Overview
4.1.5 Alnylam Pharmaceuticals News
4.2 Arrowhead
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 RNAi for Therapeutic Product Types, Application and Specification
4.2.2.1 Category One
4.2.2.2 Category Two
4.2.3 Arrowhead RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.2.4 Main Business/Business Overview
4.2.5 Arrowhead News
4.3 Dicerna Pharmaceuticals
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 RNAi for Therapeutic Product Types, Application and Specification
4.3.2.1 Category One
4.3.2.2 Category Two
4.3.3 Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.3.4 Main Business/Business Overview
4.3.5 Dicerna Pharmaceuticals News
4.4 Mirna Therapeutics
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 RNAi for Therapeutic Product Types, Application and Specification
4.4.2.1 Category One
4.4.2.2 Category Two
4.4.3 Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.4.4 Main Business/Business Overview
4.4.5 Mirna Therapeutics News
4.5 Quark Pharmaceuticals
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 RNAi for Therapeutic Product Types, Application and Specification
4.5.2.1 Category One
4.5.2.2 Category Two
4.5.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.5.4 Main Business/Business Overview
4.5.5 Quark Pharmaceuticals News
4.6 RXi Pharmaceuticals
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 RNAi for Therapeutic Product Types, Application and Specification
4.6.2.1 Category One
4.6.2.2 Category Two
4.6.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.6.4 Main Business/Business Overview
4.6.5 RXi Pharmaceuticals News
4.7 miRagen Therapeutics
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 RNAi for Therapeutic Product Types, Application and Specification
4.7.2.1 Category One
4.7.2.2 Category Two
4.7.3 miRagen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.7.4 Main Business/Business Overview
4.7.5 miRagen Therapeutics News
4.8 Gradalis
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 RNAi for Therapeutic Product Types, Application and Specification
4.8.2.1 Category One
4.8.2.2 Category Two
4.8.3 Gradalis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.8.4 Main Business/Business Overview
4.8.5 Gradalis News
4.9 Sirnaomics
4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.9.2 RNAi for Therapeutic Product Types, Application and Specification
4.9.2.1 Category One
4.9.2.2 Category Two
4.9.3 Sirnaomics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
4.9.4 Main Business/Business Overview
4.9.5 Sirnaomics News
5 Production Cost Analysis of RNAi for Therapeutic
5.1 Main Raw Materials of RNAi for Therapeutic
5.1.1 List of RNAi for Therapeutic Main Raw Materials
5.1.2 RNAi for Therapeutic Main Raw Materials Price Analysis
5.1.3 RNAi for Therapeutic Raw Materials Major Suppliers
5.1.4 RNAi for Therapeutic Main Raw Materials Market Concentration Rate
5.2 Production Cost Structure of RNAi for Therapeutic
5.2.1 Raw Materials
5.2.2 Labor Cost
5.2.3 Production Expenses
5.3 RNAi for Therapeutic Manufacturing Process/Method
6 Value Chain, Purchasing Strategy and Downstream Buyers
6.1 RNAi for Therapeutic Value Chain Analysis
6.2 Upstream Raw Materials Purchasing
6.3 Raw Materials Sources of RNAi for Therapeutic Major Vendors in 2016
6.4 Downstream Buyers
7 Marketing Strategy Analysis, Distributors/Traders
7.1 Sales Channel
7.1.1 Direct Sales
7.1.2 Indirect Sales
7.1.3 Sales Channel Development Trend
7.2 Product Market Positioning
7.2.1 Pricing Strategy
7.2.2 Brand Strategy
7.2.3 Target Client
7.3 RNAi for Therapeutic Distributors/Traders List in India
8 Market Influences Factors Analysis
8.1 Changes from the Related Industries
8.2 Substitutes Threat
8.3 Customer Preference Change
8.4 Economic/Political Environmental Change
8.5 Upstream and Downstream Fluctuation
9 India RNAi for Therapeutic Market Forecast (2017-2022)
9.1 India RNAi for Therapeutic Sales, Revenue and Price Forecast (2017-2022)
9.1.1 India RNAi for Therapeutic Sales and Growth Rate Forecast (2017-2022)
9.1.2 India RNAi for Therapeutic Revenue and Growth Rate Forecast (2017-2022)
9.1.3 India RNAi for Therapeutic Price Trend Forecast (2017-2022)
9.2 India RNAi for Therapeutic Sales Forecast by Type (2017-2022)
9.3 India RNAi for Therapeutic Sales Forecast by Application (2017-2022)
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Analyst Introduction
11.3 Data Source

List of Tables and Figures

Figure Picture of RNAi for Therapeutic
Figure India RNAi for Therapeutic Sales (volume) for Each Type (2012-2022)
Figure India RNAi for Therapeutic Sales Market Share by Types in 2016
Figure Product Picture of siRNA
Table Major Players of siRNA
Figure Product Picture of miRNA
Table Major Players of miRNA
Figure Product Picture of shRNA
Table Major Players of shRNA
Figure India RNAi for Therapeutic Sales Present Situation and Outlook by Applications (2012-2022)
Figure India RNAi for Therapeutic Sales Market Share by Types in 2016
Figure Cancer Examples
Figure Cardiovascular Examples
Figure HBV Examples
Figure Other Examples
Figure India RNAi for Therapeutic Revenue (Million USD) Status and Forecast (2012-2022)
Figure India RNAi for Therapeutic Sales (Volume) Status and Forecast (2012-2022)
Table India RNAi for Therapeutic Sales by Vendors (2012-2017)
Table India RNAi for Therapeutic Sales Market Share (%) by Vendors (2012-2017)
Figure India RNAi for Therapeutic Sales Share by Vendors in 2015
Figure India RNAi for Therapeutic Sales Share by Vendors in 2016
Table India RNAi for Therapeutic Revenue (Million USD) by Vendors (2012-2017)
Table India RNAi for Therapeutic Revenue Market Share (%) by Vendors (2012-2017)
Figure India RNAi for Therapeutic Revenue Share by Vendors in 2015
Figure India RNAi for Therapeutic Revenue Share by Vendors in 2016
Table India RNAi for Therapeutic Average Price by Vendors in 2016
Table India RNAi for Therapeutic Manufacturing Base Distribution and Sales Area by Vendors
Table Vendors RNAi for Therapeutic Product Types
Figure RNAi for Therapeutic Market Share of Top 3 Vendors
Figure RNAi for Therapeutic Market Share of Top 5 Vendors
Table India RNAi for Therapeutic Sales by Type (2012-2017)
Table India RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
Figure India RNAi for Therapeutic Sales Market Share by Type (2012-2017)
Figure 2016 India RNAi for Therapeutic Sales Market Share by Type
Table India RNAi for Therapeutic Revenue (Million USD) by Type (2012-2017)
Table India RNAi for Therapeutic Revenue Market Share by Type (2012-2017)
Figure India RNAi for Therapeutic Revenue Market Share by Type (2012-2017)
Figure 2016 India RNAi for Therapeutic Revenue Market Share by Type
Table India RNAi for Therapeutic Price by Type (2012-2017)
Table India RNAi for Therapeutic Sales by Application (2012-2017)
Table India RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
Figure India RNAi for Therapeutic Sales Market Share by Application (2012-2017)
Figure 2016 India RNAi for Therapeutic Sales Market Share by Application
Table India Market RNAi for Therapeutic Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table Arrowhead Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arrowhead RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Arrowhead RNAi for Therapeutic Market Share (2012-2017)
Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table Mirna Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mirna Therapeutics RNAi for Therapeutic Market Share (2012-2017)
Table Quark Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Quark Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table RXi Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure RXi Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table miRagen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table miRagen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure miRagen Therapeutics RNAi for Therapeutic Market Share (2012-2017)
Table Gradalis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gradalis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gradalis RNAi for Therapeutic Market Share (2012-2017)
Table Sirnaomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sirnaomics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sirnaomics RNAi for Therapeutic Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure RNAi for Therapeutic Main Raw Materials Price Trend
Table RNAi for Therapeutic Raw Materials Major Suppliers List
Figure Production Cost Structure of RNAi for Therapeutic
Figure RNAi for Therapeutic Manufacturing Process/Method
Figure RNAi for Therapeutic Value Chain Analysis
Table Raw Materials Sources of RNAi for Therapeutic Major Vendors in 2016
Table Major Buyers of RNAi for Therapeutic
Table RNAi for Therapeutic Distributors/Traders List in India
Figure India RNAi for Therapeutic Sales and Growth Rate Forecast (2017-2022)
Figure India RNAi for Therapeutic Revenue and Growth Rate Forecast (2017-2022)
Figure India RNAi for Therapeutic Price Trend Forecast (2017-2022)
Table India RNAi for Therapeutic Sales Forecast by Type (2017-2022)
Figure India RNAi for Therapeutic Sales Market Share Forecast by Type (2017-2022)
Figure India RNAi for Therapeutic Sales Market Share Forecast by Type in 2022
Table India RNAi for Therapeutic Sales Forecast by Application (2017-2022)
Figure India RNAi for Therapeutic Sales Market Share Forecast by Application (2017-2022)
Figure India RNAi for Therapeutic Sales Market Share Forecast by Application in 2022

★調査レポート[治療用RNAiのインド市場(現状と見通し)] (コード:LPI705538)販売に関する免責事項を必ずご確認ください。
★調査レポート[治療用RNAiのインド市場(現状と見通し)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆